top of page

BGI & Panomix


For over 20 years, BGI Genomics has been the world leader in genomic and proteomic services, serving clients in over 100 countries. We empower academic institutions, pharmaceutical companies, healthcare providers, and more with integrated solutions across a vast range of applications.

Our cutting-edge technology, including our own DNBseq™ sequencing platform, delivers rapid, high-quality results at cost-effective prices. Contact us today and discover how BGI Genomics can help you unlock the power of genomics and achieve your research goals.

Founded in 2013, PANOMIX is a pioneer in the field of metabolomics, providing comprehensive solutions for clinical mass spectrometry and omics research. With a team of experts from renowned institutions like Harvard University and MD Anderson Cancer Center, PANOMIX is at the forefront of innovation, offering cutting-edge metabolomics testing services, clinical products, and big data solutions.



Targeted & Untargeted Metabolomics

Targeted metabolomics analyzes a predefined set of metabolites, validating biomarkers in diverse samples. It requires standards for precise analysis. Untargeted metabolomics explores all metabolites without bias, providing comprehensive insights into small molecule profiles.


Mass Spectrometry Services

 BGI and Panomix empowers researchers to unravel complex biological mechanisms. Their state-of-the-art mass spectrometry techniques reveal protein functions in detail, from identification and characterization to their interactions and modifications. LC-MS combines liquid chromatography and mass spectrometry, separating and detecting ions to provide precise molecular information. GC-MS combines Gas Chromatography's strong separation with Mass Spectrometry's precise identification, serving as a powerful tool. It is widely used in medicine, food, and environmental analysis for its versatility and is accelerating the medical advancements and drug discovery.



Proteomics & Lipodomics 


TMT/iTRAQ utilize isobaric labeling for quantitative proteomic profiling. Label-free analysis, a mass spectrometry approach, overcomes isotope labeling constraints, retaining original sample information. DIA technology ensures comprehensive data acquisition. PRM-targeted proteomics enables selective quantification, while post-translational modification omics explores functional protein modifications. Lipidomics is also a vital metabolomics branch, focuses on diverse, water-insoluble lipid compounds categorized into glycerides, fatty acids, glycolipids, sterol lipids, and more.

bottom of page